TR200103011T2 - Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod. - Google Patents

Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.

Info

Publication number
TR200103011T2
TR200103011T2 TR2001/03011T TR200103011T TR200103011T2 TR 200103011 T2 TR200103011 T2 TR 200103011T2 TR 2001/03011 T TR2001/03011 T TR 2001/03011T TR 200103011 T TR200103011 T TR 200103011T TR 200103011 T2 TR200103011 T2 TR 200103011T2
Authority
TR
Turkey
Prior art keywords
relates
encephalopathies
type
marker protein
test kit
Prior art date
Application number
TR2001/03011T
Other languages
English (en)
Inventor
Giese Matthias
Stephen Rogers Mark
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of TR200103011T2 publication Critical patent/TR200103011T2/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Bulus bulasici sünger tipi ansefalopatilerin klinik teshisine yönelik bir metodla ilgili olup, markör proteinin degisik bir ekspresyonunun ölçülmesiyle tanimlanir. Özel tecessümlerde, bulus uyarinca metodda, ölçülen markör protein prion proteini PrP-sen veya interferon gama (IFMy), veya laminin reseptörü (LR) veya laminin reseptörü prekürsörüdür (LRP). Bulus, ayni zamanda, bulus uyarinca markör proteine özel antikorlari kullanan test kitiylede ilgilidir. Bulus, yine, bulus uyarinca markör proteini kodlayan nükleik asitle siki sartlarda hibridize olabilen oligonükleotidleri kullanan test kitiylede ilgilidir. Bulus, ayrica, bulus uyarinca bir metodda yukarida belirtilen markör proteinlere özel oligonükleotidlerin veya antikorlarin kullanimiylada ilgilidir. Bulus, ayni zamanda, bulasici sünger tipi ansefalopatilerin teshisine yönelik test kitinin kullanimiylada ilgilidir.
TR2001/03011T 1999-04-21 2000-04-20 Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod. TR200103011T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19918141A DE19918141A1 (de) 1999-04-21 1999-04-21 Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien

Publications (1)

Publication Number Publication Date
TR200103011T2 true TR200103011T2 (tr) 2002-02-21

Family

ID=7905394

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03011T TR200103011T2 (tr) 1999-04-21 2000-04-20 Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.

Country Status (26)

Country Link
US (2) US20030064424A1 (tr)
EP (1) EP1093585A1 (tr)
JP (1) JP2002543389A (tr)
KR (1) KR20020021774A (tr)
CN (1) CN1347501A (tr)
AR (1) AR023553A1 (tr)
AU (1) AU4297400A (tr)
BG (1) BG106021A (tr)
BR (1) BR0009843A (tr)
CA (1) CA2367696A1 (tr)
CO (1) CO5170446A1 (tr)
CZ (1) CZ20013771A3 (tr)
DE (1) DE19918141A1 (tr)
EA (1) EA200101021A1 (tr)
EE (1) EE200100547A (tr)
HK (1) HK1043188A1 (tr)
HU (1) HUP0200777A2 (tr)
ID (1) ID30392A (tr)
IL (1) IL145253A0 (tr)
MX (1) MXPA01010546A (tr)
NO (1) NO20015094L (tr)
PL (1) PL350985A1 (tr)
SK (1) SK15032001A3 (tr)
TR (1) TR200103011T2 (tr)
UY (1) UY26109A1 (tr)
WO (1) WO2000065357A1 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0026604D0 (en) 2000-10-31 2000-12-13 Roslin Inst Edinburgh Diagnostic method
DE10108099A1 (de) * 2001-02-19 2002-09-12 Cenas Ag Verfahren zum Nachweis spezifischer Proteine und Verwendung
CA2440960A1 (en) * 2001-03-21 2002-09-26 Exonhit Therapeutics S.A. An early pre-symptomatic prion diagnostic blood test for encephalopathies
CA2443170A1 (en) * 2001-03-30 2002-10-10 Chronix Biomedical, Inc. Diagnostic detection of nucleic acids
GB0110172D0 (en) * 2001-04-25 2001-06-20 Pa Consulting Services Improved analytical test approach for blood
AU2002344245A1 (en) * 2001-05-29 2002-12-09 Reinhold Kiehl Method for determining peptides or proteins, mass spectrometry for metals and determination of conductivity capacity
JP4093736B2 (ja) 2001-06-28 2008-06-04 株式会社日立メディコ 核磁気共鳴診断装置および診断システム
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
KR20020033126A (ko) * 2002-03-08 2002-05-04 김용선 병원성 프리온 단백의 n말단의 비효소적 당화반응 최종산물의 검출에 의한 프리온 질환의 진단
AU2003294759A1 (en) * 2002-12-03 2004-06-23 Exonhit Therapeutics S.A. An early pre-symptomatic prion diagnostic blood test for encephalopathies
RU2251699C1 (ru) * 2003-09-25 2005-05-10 Киселев Всеволод Иванович Способ ранней и доклинической диагностики цервикального рака
ES2246113B1 (es) * 2003-10-31 2007-04-01 Consejo Sup. De Invest. Cientificas Procedimiento de deteccion ante-mortem de proteinas prionicas por espectroscopia infrarroja y su uso en el diagnostico de encefalopatias espongiformes transmisibles.
US7368243B2 (en) * 2004-07-09 2008-05-06 Chronix Biomedical Detection of nucleic acids to assess risk for bovine spongiform encephalopathy
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
EP1749892B1 (en) * 2005-08-02 2008-03-19 Roche Diagnostics GmbH Nucleotide sequence for assessing TSE
US7798645B2 (en) 2006-05-16 2010-09-21 Mark Costin Roser Visual and memory stimulating retina self-monitoring system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008435A (en) * 1994-05-13 1999-12-28 The Regents Of The University Of California Detecting cow, sheep and human prions in a sample and transgenic mice used for same
US5789655A (en) * 1994-05-13 1998-08-04 The Regents Of The University Of California Transgenic animals expressing artificial epitope-tagged proteins
DE852011T1 (de) * 1995-09-14 2001-10-11 Scripps Res Inst La Jolla Für natives prp-sc spezifische antikörper
NZ332132A (en) * 1996-04-03 2000-02-28 Stichting Inst Voor Dierhouder Pre-clinical detection of prion diseases such as PrPsc
US5834593A (en) * 1996-11-05 1998-11-10 The Regents Of The University Of California Soluble form of PrPSC which is insoluble in native form
DE19648599C1 (de) * 1996-11-23 1998-02-19 Tavira Holdings Ltd Wirkdruckgeber eines Durchflußmessers
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
JP2002501385A (ja) 1997-05-30 2002-01-15 ヴァイス ステファン 可溶性ラミニン受容体前駆体及びその相互作用を阻止するための方法
US6165784A (en) * 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
US5977324A (en) * 1998-02-20 1999-11-02 The Regents Of The University Of California Process for concentrating protein with disease-related conformation
US6528269B1 (en) * 1998-06-22 2003-03-04 Case Western Reserve University Immunological agents specific for prion protein (PRP)
US6166187A (en) * 1999-03-05 2000-12-26 The Regents Of The University Of California Method of concentrating prion proteins in blood samples
GB0119339D0 (en) * 2001-08-08 2001-10-03 Medical Res Council Method

Also Published As

Publication number Publication date
AR023553A1 (es) 2002-09-04
BR0009843A (pt) 2002-02-13
HK1043188A1 (zh) 2002-09-06
US20030064424A1 (en) 2003-04-03
IL145253A0 (en) 2002-06-30
PL350985A1 (en) 2003-02-24
CA2367696A1 (en) 2000-11-02
EE200100547A (et) 2003-02-17
NO20015094D0 (no) 2001-10-19
ID30392A (id) 2001-11-29
CO5170446A1 (es) 2002-06-27
US20030129667A1 (en) 2003-07-10
UY26109A1 (es) 2000-12-29
AU4297400A (en) 2000-11-10
MXPA01010546A (es) 2002-06-04
EP1093585A1 (en) 2001-04-25
HUP0200777A2 (en) 2002-06-29
DE19918141A1 (de) 2000-10-26
BG106021A (bg) 2002-06-28
EA200101021A1 (ru) 2002-04-25
JP2002543389A (ja) 2002-12-17
SK15032001A3 (sk) 2002-02-05
CN1347501A (zh) 2002-05-01
KR20020021774A (ko) 2002-03-22
CZ20013771A3 (cs) 2002-03-13
WO2000065357A1 (en) 2000-11-02
NO20015094L (no) 2001-12-17

Similar Documents

Publication Publication Date Title
TR200103011T2 (tr) Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
JP2004503760A5 (tr)
ATE417125T1 (de) Diagnose von einer klinischen infektion einer wunde
RU2003100531A (ru) Композиции, содержащие краситель на основе производного мочевины, для выявления аналита, и способы их использования
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
RU2002104927A (ru) Способы одновременного выявления обоих компонентов связывающейся пары
ATE326484T1 (de) Monoklonaler antikörper gegen flt4-rezeptor- tyrosinkinase und dessen verwendung zur diagnose und therapie
ATE294392T1 (de) Reagenz zur bestimmung von blutplättchen- mikroteilchen
EP1537415A4 (en) METHOD FOR DIAGNOSIS OF NUTRITIONAL CANCER
DE60029413D1 (de) Enzymatische messung von mycophenolsäure
JP2007533985A5 (tr)
CA2361000A1 (en) Urinary trypsin inhibitor to diagnose aids
JP6961101B2 (ja) ウイルスおよび細菌の感染症を識別するための方法およびデバイス
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
Lakshman et al. Alcohol biomarkers: clinical significance and biochemical basis
WO2002103059A3 (en) Innate immunity markers for rapid diagnosis of infectious diseases
DE60126991D1 (de) Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE
ATE386935T1 (de) Verfahren zur auswahl bioaktiver wirkstoffe durch lumineszenzkopplung und lebendes zellensystem dafür
DK1192469T3 (da) Assay
WO2000050904A8 (de) Testkit zur analytik der faktor-viii-spaltenden protease
US7303884B1 (en) Method for indirectly determining the blood-clotting status
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
AU2021103919A4 (en) Alkaline phosphatase protein chip kit for detecting antibodies of novel coronavirus